Trials / No Longer Available
No Longer AvailableNCT03203941
ACT for CP Individual Patient Expanded Access IND Protocol
Autologous Cell Therapies for Cerebral Palsy-Chronic (ACT for CP) Individual Patient Expanded Access IND Protocol
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Charles Cox · Academic / Other
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
Individual patient expanded access protocol for a child with cerebral palsy (CP) who has autologous umbilical cord blood available and who is ineligible to participate in other stem cell studies for children with CP.
Detailed description
This protocol is part of an FDA Individual Patient Expanded Access IND submitted at the request of the parents of a child with cerebral palsy (CP) who is ineligible to participate in other stem cell studies. For this child, there are no other treatment options.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous Cord Blood Stem Cells | This is an individual patient expanded access protocol. |
Timeline
- First posted
- 2017-06-29
- Last updated
- 2020-05-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03203941. Inclusion in this directory is not an endorsement.